Redx Pharma to open new R&D center in UK
The new venture, Redx Anti-Infectives, will create 119 high value science jobs at the site, establishing a new team to develop drugs combatting resistance to antibiotics and new
Ionis Pharmaceuticals has entered a licence agreement granting global pharmaceutical company Recordati exclusive rights to develop and commercialise zilganersen to treat Alexander disease (AxD) in countries outside the US.